Emerging considerations for noninvasive prenatal testing

Clinical Chemistry

Volumn 63, Issue 5, 2017, Pages 946-953

  Korpi Steiner, Nichole ^a   Chiu, Rossa W K ^b   Chandrasekharan, Subhashini ^c   Chitty, Lyn S ^d   Evans, Mark I ^e,f   Jackson, Judith A ^g,h   Palomaki, Glenn E ⁱ  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f Fetal Medicine Foundation of America   (United States)

^g South Shore Hospital   (United States)

^h BRANDEIS UNIVERSITY   (United States)

ⁱ BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CHROMOSOME ABERRATION; CLINICAL LABORATORY; DOWN SYNDROME; EDWARDS SYNDROME; FEMALE; FETUS MONITORING; HIGH RISK PREGNANCY; HUMAN; INCIDENTAL FINDING; INFORMED CONSENT; MANDATORY REPORTING; NON INVASIVE MEASUREMENT; NONINVASIVE PRENATAL TESTING; NOTE; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TRISOMY 13; GENETIC SCREENING; HEALTH CARE QUALITY; HOSPITAL LABORATORY; ORGANIZATION AND MANAGEMENT; PREGNANCY; PROCEDURES; STANDARDS;

ANEUPLOIDY; DOWN SYNDROME; FEMALE; GENETIC TESTING; HUMANS; INCIDENTAL FINDINGS; INFORMED CONSENT; LABORATORIES, HOSPITAL; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; QUALITY ASSURANCE, HEALTH CARE;

EID: 85018354084     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.266544     Document Type: Note

References (0)